These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35290890)

  • 21. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of long noncoding RNA MNX1-AS1 in human cancers: a meta-analysis of cohort studies and bioinformatics analysis based on TCGA datasets.
    Chen K; Gan JX; Huang ZP; Liu J; Liu HP
    Bioengineered; 2021 Dec; 12(1):875-885. PubMed ID: 33685348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of lncRNA MNX1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer.
    Li AH; Zhang HH
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5618-5623. PubMed ID: 29271994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MNX1-AS1 is a novel biomarker for predicting clinical progression and poor prognosis in lung adenocarcinoma.
    Yang R; Wang L; Han M
    J Cell Biochem; 2019 May; 120(5):7222-7228. PubMed ID: 30506837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical effects and molecular mechanisms of lncRNA MNX1-AS1 in malignant tumors.
    Shen S; Zhou H
    Am J Transl Res; 2020; 12(11):7593-7602. PubMed ID: 33312391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of lncRNA AFAP1-AS1 correlates with poor prognosis and promotes tumorigenesis in colorectal cancer.
    Wang F; Ni H; Sun F; Li M; Chen L
    Biomed Pharmacother; 2016 Jul; 81():152-159. PubMed ID: 27261589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA MNX1-AS1 drives aggressive laryngeal squamous cell carcinoma progression and serves as a ceRNA to target FoxM1 by sponging microRNA-370.
    Cui X; Yu H; Yu T; Xiao D; Wang X
    Aging (Albany NY); 2021 Mar; 13(7):9900-9910. PubMed ID: 33882027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression.
    Zheng Q; Gu X; Yang Q; Chu Q; Dai Y; Chen Z
    Clin Chim Acta; 2021 Jun; 517():1-8. PubMed ID: 33607068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA MAFG-AS1: A promising therapeutic target for human cancers.
    Huang Z; Zhang M; Li J; Lou C
    Biomed Pharmacother; 2023 Jul; 163():114756. PubMed ID: 37105079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TTN-AS1 as a potential diagnostic and prognostic biomarker for multiple cancers.
    Zheng QX; Wang J; Gu XY; Huang CH; Chen C; Hong M; Chen Z
    Biomed Pharmacother; 2021 Mar; 135():111169. PubMed ID: 33433359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
    Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
    Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA MNX1-AS1 promoted osteosarcoma proliferation and invasion via inhibiting KISS1.
    Zhang YX; Cui HX; Liu L; Yi GK
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6045-6052. PubMed ID: 31364121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Emerging Role of Thymopoietin-Antisense RNA 1 as Long Noncoding RNA in the Pathogenesis of Human Cancers.
    Zheng Q; Jia J; Zhou Z; Chu Q; Lian W; Chen Z
    DNA Cell Biol; 2021 Jul; 40(7):848-857. PubMed ID: 34096793
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Zheng Y; Su L; Tan J; Dong F
    Bioengineered; 2022 Mar; 13(3):4911-4922. PubMed ID: 35152841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Non-Coding RNA
    Ma F; Zhang B; Wang Y; Lou C
    Molecules; 2024 Jul; 29(15):. PubMed ID: 39124865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy.
    Huang Z; Wang Z; Xia H; Ge Z; Yu L; Li J; Bao H; Liang Z; Cui Y; Xu Y
    Clin Chim Acta; 2023 Jan; 539():162-169. PubMed ID: 36528049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA MNX1-AS1 functions as a competing endogenous RNA to regulate epithelial-mesenchymal transition by sponging MiR-744-5p in colorectal cancer.
    Huang S; Sun Y
    Biosci Biotechnol Biochem; 2021 Feb; 85(3):568-578. PubMed ID: 33590038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
    Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of LncRNA LBX2-AS1 in cancers: functions, mechanisms and potential clinical utility.
    Su Y; Li C; Fang Y; Gu X; Zheng Q; Lu J; Li L
    Clin Transl Oncol; 2023 Feb; 25(2):293-305. PubMed ID: 36131071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long Non-coding RNA ZFPM2-AS1: A Novel Biomarker in the Pathogenesis of Human Cancers.
    Sasa GBK; Xuan C; Lyu G; Ding X; Meiyu F
    Mol Biotechnol; 2022 Jul; 64(7):725-742. PubMed ID: 35098483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.